(Total Views: 99)
Posted On: 05/19/2022 12:00:57 PM
Post# of 36550

$FBIO News Article - Mustang Bio Announces Updated Interim Data on X-Linked Severe Combined Immunodeficiency Treatment with Lentiviral Vector Gene Therapy Support Upcoming Multicenter Pivotal Phase 2 Trial for MB-107 https://marketwirenews.com/news-releases/must...13013.html


My Twitter: WhyteStocks